Transaction · 0001628280-26-066705

Canton Barry

Canton Barry, 10%, reported an open-market or private sale at Ginkgo Bioworks Holdings, Inc. involving 22369.000000 shares for an estimated $226888.77. Reported holdings after the transaction were 453951.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
DNAGinkgo Bioworks Holdings, Inc.
Trade date
Oct 19, 2026
Filing date
Oct 21, 2026
View on SEC Insider profile
Estimated value-$226kShares × reported price
Shares traded22.3k$10.14 per share
Holdings after453kIndirect · By Spouse
% of reported position traded4.7%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 476,320 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

DNA price since this filing

Daily closing prices, with the filing date and available return windows
DNA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -20.1%1w ago +19.6%1d ago +4.2%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-066705
Class A Common Stock
Transaction date
Oct 19, 2026
Filed Oct 21, 2026, 08:06 PM · 2d delay
Shares
22,369 sh
$10.14 per share
Estimated value
-$226k
Computed from shares × price
Holdings after
453,951 sh
Indirect · By Spouse

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Repeat Seller
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

  2. F2

    Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obl…

  3. F3

    The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.

  4. F4

    The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.

Original filing · 0001628280-26-066705
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

DNA